BioTech
Getting to ‘Plan B’ for psychedelic medicine: Lessons from reproductive health
The Food and Drug Administration’s decision not to approve Lykos Therapeutics’ application for MDMA (a psychedelic drug known on the street as Ecstasy or molly)
Susannah Baruch
August 11, 2024